Drug Design and Optimization Lab

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Drug Design and Optimization Lab better known as "D2OL" was a Distributed Computing project with the goal of discovering drug candidates to fight SARS, Anthrax, Smallpox and other diseases and is currently being hosted by The Rotherberg Institute. The project ended on April 15, 2009.

See also[edit]

External links[edit]